Clemente Garcia Rizo
Senior Consultant Psychiatrist, Spain
Title: Novel pharmacological treatment for resistant schizophrenia
Biography
Biography: Clemente Garcia Rizo
Abstract
The concept of pharmacological medication in treatment-resistant schizophrenia has been historically related to a unique antipsychotic: clozapine. However, despite its usefulness and in certain cases, diverse pharmacological associations have been studied, not only with dopamine regulators (first or second generation antipsychotics) but other therapeutic groups such as tetracyclines (minocycline) or anticonvulsivants (lamotrigine). The aim of the presentation is to understand the actual pharmacological options of treatment-resistant schizophrenia while delving into the actual novel therapeutic approaches such as glutamatergic agents or nicotine agonists. Non- psychiatric medications and dose reduction strategies in specific treatment-resistant subjects would be also considered.
